Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Natural Killer Cells Regulatory Role Against Hepatic Fibrosis Following Bariatric Surgery

NCT02732535 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT02732535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02732535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Natural Killer Cells Regulatory Role Against Hepatic Fibrosis Following Bariatric Surgery
Lead sponsor
Hadassah Medical Organization
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2015
Completion date
December 31, 2017
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

natural killer cell deficiency, familial isolated